Richard Scolyer, BMedSci MBBS MD FRCPA FRCPath(UK) FAHMS

Medical Director
Melanoma Institute Australia, Australia

Presentation(s):

• 63: An Externally Validated Online Tool To Calculate Personalized Probabilities Of Recurrence-Free And Overall-Survival In Stage II Melanoma Patients.

  Thursday, March 21, 2024
  2:27pm – 2:37pm ET

• 66: Improved Survival with Sentinel Node Biopsy - An Emulated Randomized Controlled Trial

  Thursday, March 21, 2024
  2:57pm – 3:07pm ET

• 59: Surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors: lessons learned from the PRADO trial

  Friday, March 22, 2024
  2:02pm – 2:14pm ET